Most immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targeting a different type of immune cell… Read more
Category: Magee-Womens Research Institute
Chemotherapy-Resistant Ovarian Cancer Cells Protect Their Neighbors
Certain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, according to a new study from University of Pittsburgh and… Read more
New Analysis Sheds Light on Link Between Ovulation and Ovarian Cancer
Women who ovulate for longer over their lifetimes have a higher risk of developing ovarian cancer, suggesting that suppressing ovulation can lower this risk. A… Read more
UPMC Magee-Led Trial Provides Reassuring Results to Women with Prolapse
The National Institutes of Health (NIH) recently featured a study led by UPMC Magee-Womens Hospital physician-scientists that provides reassuring results to women experiencing pelvic organ… Read more
New Insights About ‘Bad News’ Breast Cancer Mutation Point to Treatment Opportunities
A mutated gene found in more than 20% to 30% of breast cancer recurrences may help tumors become more aggressive and promote metastasis, according to… Read more